Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
8.29B | 6.66B | 5.78B | 5.09B | 4.33B | Gross Profit |
1.88B | 1.56B | 1.24B | 783.83M | 559.00M | EBIT |
710.68M | 530.30M | 519.11M | 228.20M | 123.00M | EBITDA |
854.38M | 627.27M | 587.61M | 258.55M | 0.00 | Net Income Common Stockholders |
441.03M | 382.88M | 328.45M | 97.14M | 32.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
688.01M | 567.69M | 719.56M | 538.29M | 193.06M | Total Assets |
6.35B | 2.91B | 2.53B | 2.02B | 1.77B | Total Debt |
2.80B | 251.54M | 330.21M | 447.63M | 420.00M | Net Debt |
2.11B | -316.15M | -389.34M | -90.66M | 226.94M | Total Liabilities |
4.71B | 1.43B | 1.46B | 1.41B | 1.27B | Stockholders Equity |
1.64B | 1.48B | 1.07B | 609.46M | 502.00M |
Cash Flow | Free Cash Flow | |||
473.20M | 102.59M | 228.92M | 277.22M | -12.88M | Operating Cash Flow |
706.64M | 342.25M | 484.60M | 351.82M | 34.73M | Investing Cash Flow |
-1.13B | -383.39M | -320.25M | -77.59M | -165.24M | Financing Cash Flow |
538.78M | -110.73M | 16.93M | 36.64M | -6.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥11.03B | 15.06 | 1.31% | 20.50% | 62.52% | ||
73 Outperform | ¥18.45B | 12.22 | 4.07% | 4.15% | -25.66% | ||
72 Outperform | ¥2.99B | 7.99 | 2.54% | 2.33% | -0.96% | ||
70 Outperform | ¥3.02B | 9.50 | 2.77% | 4.85% | 4759.88% | ||
64 Neutral | ¥4.15B | 11.14 | ― | 15.25% | 93.03% | ||
64 Neutral | ¥10.15B | 18.46 | 1.25% | 21.97% | -20.94% | ||
53 Neutral | $5.20B | 3.32 | -45.04% | 2.84% | 16.81% | -0.31% |